Observed Signal · Oct 29, 2026 · earnings · Source: SEC API · Impact: 3.7/5
10-Q Financial Filing Analysis for Cognizant (2026-10-29)
Cognizant reported Q3 2026 financial results with quarterly revenue increasing 4.6% year-over-year (4.8% in constant currency) to $5.66 billion, driven by Financial Services and CMT segments along with contributions from recently completed acquisitions (3Cloud, Astreya). Operating income reached $872 million with a GAAP operating margin of 15.4%, pressured by $51 million of restructuring charges under Project Leap, while Adjusted Operating Margin expanded 30 basis points to 16.3%. Net income increased 128.8% to $627 million, lapping a $390 million discrete tax charge in Q3 2025 related to the U.S. OBBBA enactment. Free cash flow generation enabled $1.88 billion in share repurchases year-to-date, complemented by an expanded credit facility refinanced in October 2026.
Cognizant demonstrates steady revenue growth and margin resilience amid industry-wide IT spending scrutiny while actively executing organizational restructuring under Project Leap and scaling cloud/AI capabilities via programmatic M&A.
Track Cognizant Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Q3 2026 revenue rose 4.6% year-over-year to $5,664 million, with GAAP diluted EPS rising 148.2% to $1.39 and Adjusted Diluted EPS increasing 7.2% to $1.49.
- Project Leap restructuring incurred $51 million in Q3 and $135 million year-to-date, with total program costs expected between $180 million and $250 million to generate $200 million in 2026 in-year savings.
- Subsequent to quarter-end, Cognizant entered into a New Credit Agreement on October 5, 2026, establishing a $550 million term loan and a $1.85 billion revolver maturing October 2031, and announced the acquisition of DyFlex Solutions for approximately $210 million.
Connected Companies & Entities
1 Entity mappedRelated Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
10-Q Financial Filing Analysis for CME Group (2026-10-23)
CME Group reported strong financial results for the third quarter of 2026, with total revenues increasing 13% year-over-year to $1.74 billion, up from $1.54 billion in Q3 2025. Operating income reached $1.14 billion, reflecting an operating margin expansion to 65.7% from 63.3%, while net income grew 14% to $1.04 billion ($2.89 per diluted share). Revenue expansion was driven by a 12% rise in clearing and transaction fees to $1.38 billion—fueled by a 16% increase in average daily volume to 29.4 million contracts across interest rates, equity indexes, and energy—alongside a 20% growth in market data and information services to $243.1 million. Operating expenses rose 5% to $595.9 million, primarily due to higher licensing fees tied to equity product volume and ongoing Google Cloud migration costs. For the first nine months of 2026, operating cash flows rose 5% to $3.29 billion, supporting $1.76 billion in Class A share repurchases and $3.63 billion in dividend distributions.
10-Q Financial Filing Analysis for Cloudflare
Cloudflare reported strong top-line growth in Q2 2026, with total revenue rising 36% year-over-year to $696.1 million, driven by resilient demand for its security and edge computing platforms alongside enterprise customer expansion. However, the company posted a GAAP operating loss of $205.7 million, weighed down by $150.7 million in one-time restructuring charges tied to a 20% workforce reduction initiated on May 7, 2026, as part of a strategic shift toward an 'agentic AI-first operating model.' Operationally, Cloudflare generated $56.4 million in positive free cash flow, closed the $164.2 million acquisition of VoidZero to bolster its developer toolchain, and addressed its maturing 2026 Senior Convertible Notes via a combination settlement method.
10-Q Financial Filing Analysis for CVS Health (2026-08-05)
CVS Health Corporation reported strong financial results for the second quarter of 2026, driven by top-line growth across all major operating segments. Total revenues increased 7.3% year-over-year to $106.10 billion, up from $98.92 billion in Q2 2025. Operating income saw a substantial 97.5% increase to $4.70 billion, compared to $2.38 billion in the prior-year period, primarily supported by core operational improvements and the absence of $833 million in legacy litigation charges incurred in Q2 2025. Net income attributable to CVS Health rose significantly to $2.98 billion ($2.31 diluted EPS) from $1.02 billion ($0.80 diluted EPS). Performance in the Health Care Benefits segment reflected improved medical loss dynamics, with the Medical Benefit Ratio (MBR) declining to 87.4% from 89.9% in Q2 2025, driven by improved underlying Government business performance and the absence of prior-year premium deficiency reserves. Growth was supported by the Health Services segment, where revenues climbed 11.5% to $51.80 billion, and Pharmacy & Consumer Wellness, which posted a 2.9% increase in pharmacy same-store sales aided by Rite Aid file acquisitions. In regulatory matters, CVS reached a proposed settlement with the FTC to resolve outstanding PBM and pharmacy inquiries.
Receive all future signals for Cognizant & competitors in your briefing
Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.